Study design and patients
This prospective randomized controlled study was approved by the ethics committee of our hospital on February 28, 2022 (approval number: LW2022004) and was registered in the Chinese Clinical Trial Registry (No. ChiCTR2200057324, date of first registration: 08/03/ 2022) before the first patient enrollment. All patients were informed of the purpose of the study and consented to participate. A flowchart was used for patient enrollment and allocation under the Consolidated Standards of Reporting Trials (CONSORT) guidelines.